Your SlideShare is downloading. ×
antisense technology
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

antisense technology

11,945
views

Published on

presentation................

presentation................

Published in: Education

3 Comments
6 Likes
Statistics
Notes
No Downloads
Views
Total Views
11,945
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
612
Comments
3
Likes
6
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. ANTISENSE TECHNOLOGY Presented By Desh Bandhu Gangwar M.Tech Biotech (2 year) Concerned Faculty Dr. Gunjan Garg Assistant Professor School of Biotechnology
  • 2. INTRODUCTIONWhat is AntisenseTechnology ?
  • 3. In this technique Short segments of single stranded DNA called oligo de oxy nucleotides are introduced.These oligonucleotides are complementary to the mRNA, which physically bind to the mRNA.
  • 4. Antisense technology prevent the synthesis of specific protein.Antisense technologies are a suite of techniques that, together form a very powerful weapon for studying gene function and for discovering more specific treatments of disease.
  • 5. Antisense OligonucleotidesWhat are AntisenseOligonucleotides?
  • 6. The antisense effect of a oligonucleotide sequence was first demonstrated in 1970s by Zamecnik and Stephenson, in Rous sarcoma virus.AS-ONs usually consist of 15– 20 nucleotides, which are complementary to their target mRNA.
  • 7. When these AS-ON combinedwith target mRNA, a DNA/RNAhybrid form,which degraded bythe enzyme RNase H. RNase H
  • 8. RNase H is a non-specificendonuclease, catalyzes thecleavage of RNA via hydrolyticmechanism.RNase H has ribonucleaseactivity cleaves the 3’-O-P bondof RNA in a DNA/RNA duplex.
  • 9. Mechanism of antisense activity
  • 10. Types Of AS-ONFirst generation AS-ONSecond generation AS-ONThird generation AS-ON
  • 11. A successful AS-ON depends on the followingcharacteristics: Unique DNA sequence Efficient cellular uptake Minimal nonspecific binding Target specific hybridization Non-toxic antisense construct Nuclease resistant to protect AS-ON
  • 12. First generation AS-ONFirstsynthesized by Eckstein and colleagues.Phosphorothioate - oligo deoxy nucleotides are the major representatives of first generation DNA analogs that are the best known.
  • 13. Sites of chemical modification
  • 14. Phosphorothioate linkages in Ons primarily used to enhance their nuclease resistance.Inthis class of ONs, non bridging oxygen atoms in phopho-diester bond is replaced by sulfur.They first used as AS-ONs for the inhibition of HIV.
  • 15. Characterstics of first generation AS-ONBetter stability to nucleases but still degrades.Decreased affinity to target mRNA.Enhanced specificity of hybridization.Toxic in nature.Can activate R Nase H.
  • 16. Second generation AS-ONSecond generation ONs containing nucleotides with alkyl modifications at the 2’ position of the ribose. 2’-O-methyl and 2’-O-methoxy- ethyl RNA are the most important member of this class.
  • 17. Characterstics of second generation AS-ONBest stability to nucleases.Increased affinity to target mRNA.Less toxic than first generation AS-ON.Can not activate R Nase.
  • 18. Third generation AS-ONNewest and most promising.Enhance binding affinity and biostability.Peptide nucleic acids (PNAs)Locked nucleic acid (LNA)Tricyclo-DNA (tcDNA)Cyclohexene nucleic acids (CeNA)
  • 19. Peptide nucleic acids In PNAs the deoxyribose phosphate backbone is replaced by polyamide linkages, which is composed of repeating N-(2-aminoethyl)-glycine units, linked by peptide bonds PNA was first introduced by Nielsen and coworkers in 1991. They are electrostatically neutral molecules
  • 20. Locked nucleic acid LNA was synthesized by Jesper Wengel in 1998. The ribose moiety of LNA nucleotide is modified with an extra bridge connecting the 2 oxygen and 4 carbon
  • 21. RibozymesThomas and coworkers coined the term ‘ribozymes.Ribozymes are RNA molecules that have catalytic activity.Ribozyme Bind to the target RNA moiety and inactivate it by cleaving the phosphodiester backbone at a specific cutting site.
  • 22. Mechanism of Ribozymes
  • 23. Types Of RibozymesTetrahymena group I intron RNase PHammer head ribozymeHairpin ribozymeHepatitis delta virus ribozyme
  • 24. Cycle of RNA cleavage by hammerhead ribozyme
  • 25. Ribozymes in clinical trialsANGIOZYME - VEGF-receptor1HERZYME - HER-2HEPTAZYM
  • 26. RNA interference RNA interference (RNAi) is a system within living cells that takes part in controlling genes activity. Twotypes of small RNA molecules – (miRNA) and (siRNA) are central to RNA interference. Melloand Fire named the process RNAi, were awarded the Nobel Prize.
  • 27. Mechanism of RNA interference
  • 28. Comparision Of different Antisense stratgies
  • 29. Applications Of Antisense technologies Story of Flavr Savr…
  • 30. Antisense therapyß-thalassemiaCytomegalovirus retinitisHemorrhagic fever virusesDuchenne muscular dystrophyCancerHIV/AIDSHigh cholesterol
  • 31. Antisense Drug Therapy
  • 32. REFERENCE Gene cloning and DNA analysis, Fifth edition By T.A Brown Page no. 235 Walton, S. P., Roth, C. M., Yarmush, M. L. “Antisense Technology.”The Biomedical Engineering Handbook: Second Edition. Indian journal of chemistry vol. 48 B December 2009, pp. 1721-1726 Indian journal of biotechnology vol 4,JUL 2005,pp. 316 -322 Eur. J. Biochem. 270,1628–1644 Clinical and Experimental Pharmacology and Physiology (2006) 33, 533–540
  • 33. QUERIES?
  • 34. THANK YOU

×